Imfinzi recommended for EU approval for LS-SCLC 3 February 2025 Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung…
AstraZeneca ditches £450m investment in UK plant The drugs giant blames "protracted" talks with the government as well as differences over funding.…
Vodafone, AstraZeneca, Amazon and Santander in busy week ahead Vodafone, Santander, GSK, AstraZeneca and Diageo are among those teeing up a busy week ahead. Vodafone, as its £15 billion merger…
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, IIPR, Block, and Crocs and Encourages Investors to Contact the Firm NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Enhertu approved in US for breast cancer post ET 28 January 2025 Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following…